Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Replicative Cell Senescence02:15

Replicative Cell Senescence

3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Genomics comes of age: From research tool to routine care.

Journal of internal medicine·2026
Same author

Myxoid neoplasms with MAP3K kinase fusion: a study of 39 cases.

Histopathology·2026
Same author

Evaluation of the Feasibility and Safety of Ifosfamide-Based Chemotherapy Regimens for Sarcomas in the Outpatient Setting.

JCO oncology practice·2026
Same author

MiT fusions, TSC1-TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComa.

Nature communications·2026
Same author

Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

Future oncology (London, England)·2026
Same author

Stromal peroxidasin drives early tumor growth in breast cancer.

iScience·2026

Video Experimental Relacionado

Updated: Aug 13, 2025

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.4K

Los defectos hereditarios en los telómeros y la función mitótica predisponen selectivamente a los sarcomas

Mandy L Ballinger1,2, Swetansu Pattnaik1,2, Piyushkumar A Mundra1,2

  • 1Garvan Institute of Medical Research, Sydney 2010, Australia.

Science (New York, N.Y.)
|January 19, 2023
PubMed
Resumen

Este estudio revela dos vías genéticas clave del cáncer específicas para los sarcomas, que involucran la división celular y el mantenimiento de los telómeros. Estos hallazgos destacan los defectos hereditarios en la biología mitótica y telomérica como cruciales para el riesgo de sarcoma.

Más Videos Relacionados

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K
Observing Mitotic Division and Dynamics in a Live Zebrafish Embryo
10:10

Observing Mitotic Division and Dynamics in a Live Zebrafish Embryo

Published on: July 15, 2016

12.2K

Videos de Experimentos Relacionados

Last Updated: Aug 13, 2025

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.4K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K
Observing Mitotic Division and Dynamics in a Live Zebrafish Embryo
10:10

Observing Mitotic Division and Dynamics in a Live Zebrafish Embryo

Published on: July 15, 2016

12.2K

Área de la Ciencia:

  • En el campo de la oncología
  • La genética
  • Biología del cáncer

Sus antecedentes:

  • Las malignidades epiteliales han sido el foco principal de la investigación genética del cáncer.
  • Los sarcomas, cánceres raros de mesodermo embrionario, carecen de un análisis extenso de la vía genética.
  • Comprender las vías específicas del sarcoma es crucial para la investigación del cáncer raro.

Objetivo del estudio:

  • Identificar las vías genéticas del cáncer específicas para los cánceres mesenquimales, en particular los sarcomas.
  • Investigar el papel de las variantes germinales en la susceptibilidad al sarcoma.
  • Para descubrir nuevas bases genéticas de tipos raros de cáncer.

Principales métodos:

  • Se realizó la secuenciación de la línea germinal de todo el genoma en 1644 casos de sarcoma esporádico y 3205 controles sanos.
  • Un diseño de fenotipo extremo combinó la carga de variantes raras y el análisis ontológico.
  • El análisis estadístico se centró en la identificación de vías genéticas específicas del sarcoma.

Principales resultados:

  • Se identificaron dos vías específicas para el sarcoma: la función mitótica y el mantenimiento de los telómeros.
  • Las variantes en los genes centrosómicos están asociadas con tumores malignos de la vaina nerviosa periférica y tumores del estroma gastrointestinal.
  • Los defectos hereditarios en el complejo de shelterin se correlacionan con un mayor riesgo de sarcoma, melanoma y cáncer de tiroides.

Conclusiones:

  • Los defectos hereditarios en la biología mitótica y telomérica juegan un papel específico en la susceptibilidad al sarcoma.
  • Esta investigación amplía nuestra comprensión de la base genética de los cánceres mesenquimales raros.
  • Los hallazgos sugieren nuevas vías potenciales para diagnosticar y tratar los sarcomas.